空間蛋白質體學市場－全球產業規模、佔有率、趨勢、機會及預測（按產品、技術、工作流程、樣品類型、最終用途、地區和競爭格局分類，2021-2031年）

全球太空蛋白質體學市場預計將從 2025 年的 1.0409 億美元成長到 2031 年的 2.1271 億美元，複合年成長率為 12.65%。

空間蛋白質體學是一門專門用於繪製和量化完整組織內蛋白質分佈的分析學科，它能夠保留細胞微環境，而這種微環境在批量測序過程中往往會受到破壞。該市場的主要促進因素是腫瘤學領域對精準生物標記鑑定的迫切需求，以及為實現個人化醫療而日益成長的揭示細胞異質性的需求。這些因素促使製藥研發人員採用太空技術，透過研究分子在其自然環境中的相互作用來加速藥物檢驗。

儘管前景廣闊，但該市場仍面臨著許多挑戰，例如設備高成本以及管理複雜空間數據所需的大量生物資訊工作。這種複雜性常常阻礙小規模研究機構採用此技術。然而，正如近期發表的科學論文所表明的那樣，該領域的發展勢頭依然強勁。據美國癌症研究協會 (AACR) 稱，其 2024 年年會預計將收到約 7,200 篇摘要，凸顯了空間生物學作為癌症研究轉型關鍵主題的重要性。如此活躍的研究活動表明，空間分析在推動現代生物醫學研究方面發揮著至關重要的作用。

市場促進因素

空間體學在精準醫療和腫瘤免疫學領域的快速整合是市場成長的主要動力。隨著臨床治療重點從廣譜療法轉向標靶治療，對亞細胞級腫瘤微環境分析的需求日益成長。這有助於識別批量定序常常遺漏的預測性生物標記物，從而提高免疫療法的療效。癌症發生率的不斷攀升進一步強化了對這種精細分析的需求。根據美國癌症協會發布的《2024年癌症事實與數據》報告，預計2024年美國將新增約2,001,140例癌症病例。如此高的發病率促使製藥公司將空間蛋白質體學納入臨床試驗，以便更好地了解抗藥性機制並改善治療效果。

此外，策略聯盟和產業整合正在推動多組體學整合並鞏固市場地位。主要儀器製造商正積極收購專注於太空生物學的公司，以開發結合成像和質譜的綜合工作流程。例如，根據2024年5月的新聞稿，布魯克公司以約3.926億美元現金完成了對其NanoString業務部門的收購。此類策略整合最大限度地減少了產業碎片化，並為研究人員提供了一個用於資料收集和分析的整合平台。專業供應商的財務成功也反映了這項商業性進展。 Akoya Biosciences公佈的2023會計年度總收入為9,660萬美元，證實了空間生物學解決方案規模的不斷擴大。

市場挑戰

儀器設備所需的大量資本投入，以及處理複雜空間資料集所需的龐大生物資訊負擔，對全球太空蛋白質體學市場的成長構成了重大障礙。這雙重壁壘造成了極高的進入門檻，實際上將這些先進技術的應用限制在資金雄厚的製藥公司和大型研究中心，而將小規模的學術和臨床實驗室排除在外。這導致市場滲透率有限，技術普及速度放緩，進而阻礙了太空分析技術在個人化醫療和生物標記識別等重要領域的廣泛應用。

此外，空間解析度資料的管理和解讀困難會造成營運瓶頸，阻礙研究工作流程。這項挑戰是數據密集型技術產業普遍通用的難題。根據皮斯托亞聯盟 (Pistoia Alliance) 2024 年的一項調查，52% 的生命科學專業人士認為「低品質且管理不善的資料集」是採用先進分析工作流程的主要障礙。這項數據凸顯了組織在整合複雜資料流時所面臨的龐大資源需求，直接影響空間蛋白質體學的擴充性，並限制了其向常規臨床應用的市場發展。

市場趨勢

在空間蛋白質體學中，人工智慧 (AI) 和深度學習的融合對於克服數據解讀障礙至關重要。隨著資料集日益包含複雜的多模態層，AI 演算法正被用於自動化細胞分割和識別預測性生物標記物，從而加速從原始影像到臨床應用的轉化。近期的一些進展也印證了這種向可擴展解決方案的轉變。根據《精準醫學在線》(Precision Medicine Online) 2024 年 4 月的一篇文章報道，Owkin 預計到年底將為數千名患者產生多模態腫瘤微環境圖譜，以支持臨床決策。

同時，對無偏倚亞細胞解析度的需求推動了對高通量多重分析能力的偏好。研究人員正在探索能夠識別特定組織區域中大量蛋白質庫的技術，從而促進發現標準抗體組合無法檢測到的新治療標靶。這種對深度蛋白質體學洞察的需求正在推動對結合先進顯微鏡技術和質譜技術的下一代平台的投資。例如，根據2024年12月的新聞稿，Syncell已籌集了總計3,000萬美元的資金籌措，其中包括1,500萬美元的A輪融資，用於加速其「Microscoop」平台的全球商業化。該平台支援高精度、無偏倚的空間蛋白質體學分析。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球空間蛋白質體學市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（設備、耗材、軟體）
  • 按技術（成像技術、質譜技術、定序技術等）
  • 依工作流程（樣品製備、儀器分析、數據分析）
  • 依樣本類型（FFPE、冷凍切片檢查標本）
  • 透過申請（學術/轉化研究機構、製藥/生物技術公司等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美空間蛋白質體學市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲空間蛋白質體學市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區空間蛋白質體學市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲空間蛋白質體學市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美空間蛋白質體學市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球空間蛋白質體學市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• 10x Genomics, Inc.
• Bruker Corporation
• Standard BioTools Inc.
• Bruker Spatial Biology, Inc.
• Akoya Biosciences, Inc.
• PerkinElmer, Inc.
• Danaher Corporation
• Bio-Techne Corporation
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Spatial Proteomics Market is projected to expand from USD 104.09 Million in 2025 to USD 212.71 Million by 2031, reflecting a compound annual growth rate of 12.65%. Spatial proteomics functions as a specialized analytical domain that maps and quantifies protein distribution within intact tissues, thereby maintaining the cellular microenvironment often compromised during bulk sequencing. The market is primarily driven by the urgent need for accurate biomarker identification in oncology and a growing necessity to decipher cellular heterogeneity for personalized medicine. These drivers are encouraging pharmaceutical developers to adopt spatial technologies to expedite drug validation by studying molecular interactions in their natural context.

Despite these growth prospects, the market faces significant hurdles related to the high expense of equipment and the substantial bioinformatics workload required to manage complex spatial data. This complexity frequently impedes adoption by smaller research entities; however, sector momentum remains strong as evidenced by recent scientific contributions. According to the American Association for Cancer Research, the organization received nearly 7,200 abstracts for its 2024 annual meeting, where spatial biology featured as a prevailing theme transforming cancer research. This volume of activity highlights the critical role of spatial profiling in advancing modern biomedical inquiry.

Market Driver

The rapid integration of spatial omics into precision medicine and immuno-oncology acts as a major catalyst for market growth. As clinical focus shifts from broad-spectrum therapies to targeted approaches, there is a rising demand to analyze the tumor microenvironment with subcellular precision. This enables the identification of predictive biomarkers often missed by bulk sequencing, thereby improving immunotherapy efficacy. The push for such detailed analysis is reinforced by the increasing prevalence of cancer; according to the American Cancer Society's 'Cancer Facts & Figures 2024' report, approximately 2,001,140 new cancer cases were projected in the United States for the year. This incidence rate drives pharmaceutical companies to incorporate spatial proteomics into clinical trials to better understand drug resistance and enhance treatment results.

Furthermore, strategic alliances and industry consolidation are strengthening the market framework by facilitating multi-omics integration. Major instrument manufacturers are actively acquiring specialized spatial biology companies to develop comprehensive workflows combining imaging with mass spectrometry. For example, according to a May 2024 press release, Bruker Corporation finalized its acquisition of the NanoString business for roughly $392.6 million in cash. Such strategic consolidations minimize sector fragmentation and offer researchers unified platforms for data collection and analysis. The financial success of dedicated vendors reflects this commercial progress; Akoya Biosciences reported a total annual revenue of $96.6 million for the fiscal year 2023, underscoring the expanding scale of spatial biology solutions.

Market Challenge

The substantial capital investment required for instrumentation, coupled with the immense bioinformatics load needed to process complex spatial datasets, poses a significant obstacle to the growth of the Global Spatial Proteomics Market. These dual barriers establish a high barrier to entry, effectively confining the use of these advanced technologies to well-funded pharmaceutical firms and large research hubs while sidelining smaller academic and clinical laboratories. Consequently, the market suffers from limited instrument distribution and a decelerated rate of technology uptake, which hinders the widespread implementation of spatial profiling in vital sectors like personalized medicine and biomarker identification.

Moreover, the difficulty of managing and interpreting spatially resolved data creates operational bottlenecks that impede research workflows. This challenge mirrors broader industry issues with data-intensive technologies; according to the Pistoia Alliance in 2024, 52% of life science professionals identified low-quality and poorly curated datasets as the main hurdle to adopting advanced analytical workflows. This statistic highlights the considerable resource demands organizations encounter when integrating complex data streams, which directly affects the scalability of spatial proteomics and restricts the market's progression into routine clinical applications.

Market Trends

The incorporation of artificial intelligence and deep learning is becoming indispensable for overcoming data interpretation hurdles in spatial proteomics. As datasets increasingly involve complex multi-modal layers, AI algorithms are being utilized to automate cell segmentation and pinpoint predictive biomarkers, thereby accelerating the transition from raw imaging to clinical utility. This shift toward scalable solutions is demonstrated by recent industry developments; according to Precision Medicine Online in April 2024, Owkin anticipates generating multimodal tumor microenvironment profiles for thousands of patients by year-end to support clinical decision-making.

Concurrently, there is a growing preference for high-plex profiling capabilities, fueled by the need for unbiased, subcellular resolution. Researchers are seeking technologies capable of identifying extensive protein libraries in specific tissue areas, facilitating the discovery of new therapeutic targets that standard antibody panels cannot detect. This requirement for deeper proteomic insight is driving investment in next-generation platforms that merge advanced microscopy with mass spectrometry. For instance, according to a December 2024 press release, Syncell raised a total of $30 million, including a $15 million Series A round, to speed up the global commercialization of its Microscoop platform, which supports high-precision, unbiased spatial proteomic discovery.

Key Market Players

• 10x Genomics, Inc.
• Bruker Corporation
• Standard BioTools Inc.
• Bruker Spatial Biology, Inc.
• Akoya Biosciences, Inc.
• PerkinElmer, Inc.
• Danaher Corporation
• Bio-Techne Corporation
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc

Report Scope

In this report, the Global Spatial Proteomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spatial Proteomics Market, By Product

• Instruments
• Consumables
• Software

Spatial Proteomics Market, By Technology

• Imaging-based Technologies
• Mass Spectrometry-based Technologies
• Sequencing-based Technologies
• Others

Spatial Proteomics Market, By Workflow

• Sample Preparation
• Instrumental Analysis
• Data Analysis

Spatial Proteomics Market, By Sample Type

• FFPE
• Fresh Frozen

Spatial Proteomics Market, By End Use

• Academic & Translational Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others

Spatial Proteomics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Proteomics Market.

Available Customizations:

Global Spatial Proteomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Proteomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Consumables, Software)
  • 5.2.2. By Technology (Imaging-based Technologies, Mass Spectrometry-based Technologies, Sequencing-based Technologies, Others)
  • 5.2.3. By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis)
  • 5.2.4. By Sample Type (FFPE, Fresh Frozen)
  • 5.2.5. By End Use (Academic & Translational Research Institutes, Pharmaceutical and Biotechnology Companies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Spatial Proteomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Workflow
  • 6.2.4. By Sample Type
  • 6.2.5. By End Use
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spatial Proteomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Workflow
      • 6.3.1.2.4. By Sample Type
      • 6.3.1.2.5. By End Use
  • 6.3.2. Canada Spatial Proteomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Workflow
      • 6.3.2.2.4. By Sample Type
      • 6.3.2.2.5. By End Use
  • 6.3.3. Mexico Spatial Proteomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Workflow
      • 6.3.3.2.4. By Sample Type
      • 6.3.3.2.5. By End Use

7. Europe Spatial Proteomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Workflow
  • 7.2.4. By Sample Type
  • 7.2.5. By End Use
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Spatial Proteomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Sample Type
      • 7.3.1.2.5. By End Use
  • 7.3.2. France Spatial Proteomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Sample Type
      • 7.3.2.2.5. By End Use
  • 7.3.3. United Kingdom Spatial Proteomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Sample Type
      • 7.3.3.2.5. By End Use
  • 7.3.4. Italy Spatial Proteomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Workflow
      • 7.3.4.2.4. By Sample Type
      • 7.3.4.2.5. By End Use
  • 7.3.5. Spain Spatial Proteomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Workflow
      • 7.3.5.2.4. By Sample Type
      • 7.3.5.2.5. By End Use

8. Asia Pacific Spatial Proteomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Workflow
  • 8.2.4. By Sample Type
  • 8.2.5. By End Use
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Spatial Proteomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Sample Type
      • 8.3.1.2.5. By End Use
  • 8.3.2. India Spatial Proteomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Sample Type
      • 8.3.2.2.5. By End Use
  • 8.3.3. Japan Spatial Proteomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Sample Type
      • 8.3.3.2.5. By End Use
  • 8.3.4. South Korea Spatial Proteomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Sample Type
      • 8.3.4.2.5. By End Use
  • 8.3.5. Australia Spatial Proteomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Sample Type
      • 8.3.5.2.5. By End Use

9. Middle East & Africa Spatial Proteomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Workflow
  • 9.2.4. By Sample Type
  • 9.2.5. By End Use
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Spatial Proteomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Sample Type
      • 9.3.1.2.5. By End Use
  • 9.3.2. UAE Spatial Proteomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Sample Type
      • 9.3.2.2.5. By End Use
  • 9.3.3. South Africa Spatial Proteomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Sample Type
      • 9.3.3.2.5. By End Use

10. South America Spatial Proteomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Workflow
  • 10.2.4. By Sample Type
  • 10.2.5. By End Use
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Spatial Proteomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Sample Type
      • 10.3.1.2.5. By End Use
  • 10.3.2. Colombia Spatial Proteomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Sample Type
      • 10.3.2.2.5. By End Use
  • 10.3.3. Argentina Spatial Proteomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Sample Type
      • 10.3.3.2.5. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Spatial Proteomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 10x Genomics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bruker Corporation
• 15.3. Standard BioTools Inc.
• 15.4. Bruker Spatial Biology, Inc.
• 15.5. Akoya Biosciences, Inc.
• 15.6. PerkinElmer, Inc.
• 15.7. Danaher Corporation
• 15.8. Bio-Techne Corporation
• 15.9. S2 Genomics, Inc.
• 15.10. Seven Bridges Genomics Inc

16. Strategic Recommendations

17. About Us & Disclaimer